Loading…

Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection

Abstract Background Liver fibrosis is accelerated in patients co-infected with human immunodeficiency virus and hepatitis C viruses. Aims We investigated the correlation between liver fibrosis, immune activation and microbial translocation. Methods This cross-sectional study included patients with h...

Full description

Saved in:
Bibliographic Details
Published in:Digestive and liver disease 2015-03, Vol.47 (3), p.218-225
Main Authors: Sacchi, Paolo, Cima, Serena, Corbella, Marta, Comolli, Giuditta, Chiesa, Antonella, Baldanti, Fausto, Klersy, Catherine, Novati, Stefano, Mulatto, Patrizia, Mariconti, Mara, Bazzocchi, Chiara, Puoti, Massimo, Pagani, Laura, Filice, Gaetano, Bruno, Raffaele
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c521t-7cd45e4010af553566f7a30ef83af46b3faf9789ee5fc03b4a0b5a3021e3d3283
cites cdi_FETCH-LOGICAL-c521t-7cd45e4010af553566f7a30ef83af46b3faf9789ee5fc03b4a0b5a3021e3d3283
container_end_page 225
container_issue 3
container_start_page 218
container_title Digestive and liver disease
container_volume 47
creator Sacchi, Paolo
Cima, Serena
Corbella, Marta
Comolli, Giuditta
Chiesa, Antonella
Baldanti, Fausto
Klersy, Catherine
Novati, Stefano
Mulatto, Patrizia
Mariconti, Mara
Bazzocchi, Chiara
Puoti, Massimo
Pagani, Laura
Filice, Gaetano
Bruno, Raffaele
description Abstract Background Liver fibrosis is accelerated in patients co-infected with human immunodeficiency virus and hepatitis C viruses. Aims We investigated the correlation between liver fibrosis, immune activation and microbial translocation. Methods This cross-sectional study included patients with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) mono-infections, HIV/HCV co-infection, and healthy controls (20 subjects/group). Peripheral blood was analysed to determine the levels of Forkhead box 3 (Foxp3) T cells, TGF-β1, CD14 (soluble and surface isoforms), IL-17 and bacterial translocation products. These measurements were correlated to the severity of liver fibrosis, measured with the FIB-4 score and transient elastography. Results Foxp3T cell levels were significantly elevated in HIV mono-infected and co-infected groups ( p < 0.0005). FIB-4 and liver stiffness values inversely correlated with TGF-β1 ( p = 0.0155 and p = 0.0498). Bacterial DNA differed significantly in the HIV-positive compared to the other groups: HIV/HCV co-infected subjects had significantly higher serum levels of bacterial translocation products, CD14, and IL-17 levels ( p < 0.001). Conclusions Fibrosis stage in HIV/HCV co-infection may be influenced by immune activation due either by viral infections or to bacterial translocation.
doi_str_mv 10.1016/j.dld.2014.11.012
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1658415389</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S159086581400807X</els_id><sourcerecordid>1658415389</sourcerecordid><originalsourceid>FETCH-LOGICAL-c521t-7cd45e4010af553566f7a30ef83af46b3faf9789ee5fc03b4a0b5a3021e3d3283</originalsourceid><addsrcrecordid>eNp9kU1v1DAQhi1ERUvhB3BBOXIgqccfiVdISGhV2EorcQAqbpbjjCVvk7jYyUpV_zxOU3rg0JM_5nlHmmcIeQe0Agr1xaHq-q5iFEQFUFFgL8gZqEaVXNbsZb7LDS1VLdUpeZ3SgVIGtaSvyCmTUohaNmfkfu-PGAvn2xiSTx-LwdsYWm_6YopmTH2wZvJhLMzYFX4Y5hELYyd_XH8HE28wpsKPxe7q-gHaba_z06FdgLTmHqoXS8WG8qn4hpw40yd8-3iek19fL39ud-X--7er7Zd9aSWDqWxsJyQKCtQ4KfNotWsMp-gUN07ULXfGbRq1QZTOUt4KQ1uZAQbIO84UPycf1r63MfyZMU168Mli35sRw5x0lqIESK42GYUVzRJSiuj0bfR5yDsNVC_O9UFn53pxrgF0dp4z7x_bz-2A3VPin-QMfFoBzEMePUadrMfRYudjNqG74J9t__m_tO396K3pb_AO0yHMccz2NOjENNU_lqUvOwdBqaLNb_4XQ8-m5g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1658415389</pqid></control><display><type>article</type><title>Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection</title><source>ScienceDirect Journals</source><creator>Sacchi, Paolo ; Cima, Serena ; Corbella, Marta ; Comolli, Giuditta ; Chiesa, Antonella ; Baldanti, Fausto ; Klersy, Catherine ; Novati, Stefano ; Mulatto, Patrizia ; Mariconti, Mara ; Bazzocchi, Chiara ; Puoti, Massimo ; Pagani, Laura ; Filice, Gaetano ; Bruno, Raffaele</creator><creatorcontrib>Sacchi, Paolo ; Cima, Serena ; Corbella, Marta ; Comolli, Giuditta ; Chiesa, Antonella ; Baldanti, Fausto ; Klersy, Catherine ; Novati, Stefano ; Mulatto, Patrizia ; Mariconti, Mara ; Bazzocchi, Chiara ; Puoti, Massimo ; Pagani, Laura ; Filice, Gaetano ; Bruno, Raffaele</creatorcontrib><description>Abstract Background Liver fibrosis is accelerated in patients co-infected with human immunodeficiency virus and hepatitis C viruses. Aims We investigated the correlation between liver fibrosis, immune activation and microbial translocation. Methods This cross-sectional study included patients with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) mono-infections, HIV/HCV co-infection, and healthy controls (20 subjects/group). Peripheral blood was analysed to determine the levels of Forkhead box 3 (Foxp3) T cells, TGF-β1, CD14 (soluble and surface isoforms), IL-17 and bacterial translocation products. These measurements were correlated to the severity of liver fibrosis, measured with the FIB-4 score and transient elastography. Results Foxp3T cell levels were significantly elevated in HIV mono-infected and co-infected groups ( p &lt; 0.0005). FIB-4 and liver stiffness values inversely correlated with TGF-β1 ( p = 0.0155 and p = 0.0498). Bacterial DNA differed significantly in the HIV-positive compared to the other groups: HIV/HCV co-infected subjects had significantly higher serum levels of bacterial translocation products, CD14, and IL-17 levels ( p &lt; 0.001). Conclusions Fibrosis stage in HIV/HCV co-infection may be influenced by immune activation due either by viral infections or to bacterial translocation.</description><identifier>ISSN: 1590-8658</identifier><identifier>EISSN: 1878-3562</identifier><identifier>DOI: 10.1016/j.dld.2014.11.012</identifier><identifier>PMID: 25544657</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Adult ; Bacterial Translocation ; Biomarkers - blood ; Case-Control Studies ; CD4-Positive T-Lymphocytes - cytology ; Coinfection ; Cross-Sectional Studies ; DNA, Bacterial - genetics ; Elasticity Imaging Techniques ; Female ; Gastroenterology and Hepatology ; Hepacivirus ; Hepatitis C - immunology ; HIV immunity ; HIV Infections - immunology ; HIV/HCV co-infection ; Humans ; Interleukin-17 - blood ; Linear Models ; Lipopolysaccharide Receptors - blood ; Liver Cirrhosis - diagnosis ; Liver Cirrhosis - virology ; Liver fibrosis ; Male ; Middle Aged ; RNA, Viral - genetics ; Transforming Growth Factor beta1 - blood</subject><ispartof>Digestive and liver disease, 2015-03, Vol.47 (3), p.218-225</ispartof><rights>Editrice Gastroenterologica Italiana S.r.l.</rights><rights>2014 Editrice Gastroenterologica Italiana S.r.l.</rights><rights>Copyright © 2014 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c521t-7cd45e4010af553566f7a30ef83af46b3faf9789ee5fc03b4a0b5a3021e3d3283</citedby><cites>FETCH-LOGICAL-c521t-7cd45e4010af553566f7a30ef83af46b3faf9789ee5fc03b4a0b5a3021e3d3283</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25544657$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sacchi, Paolo</creatorcontrib><creatorcontrib>Cima, Serena</creatorcontrib><creatorcontrib>Corbella, Marta</creatorcontrib><creatorcontrib>Comolli, Giuditta</creatorcontrib><creatorcontrib>Chiesa, Antonella</creatorcontrib><creatorcontrib>Baldanti, Fausto</creatorcontrib><creatorcontrib>Klersy, Catherine</creatorcontrib><creatorcontrib>Novati, Stefano</creatorcontrib><creatorcontrib>Mulatto, Patrizia</creatorcontrib><creatorcontrib>Mariconti, Mara</creatorcontrib><creatorcontrib>Bazzocchi, Chiara</creatorcontrib><creatorcontrib>Puoti, Massimo</creatorcontrib><creatorcontrib>Pagani, Laura</creatorcontrib><creatorcontrib>Filice, Gaetano</creatorcontrib><creatorcontrib>Bruno, Raffaele</creatorcontrib><title>Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection</title><title>Digestive and liver disease</title><addtitle>Dig Liver Dis</addtitle><description>Abstract Background Liver fibrosis is accelerated in patients co-infected with human immunodeficiency virus and hepatitis C viruses. Aims We investigated the correlation between liver fibrosis, immune activation and microbial translocation. Methods This cross-sectional study included patients with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) mono-infections, HIV/HCV co-infection, and healthy controls (20 subjects/group). Peripheral blood was analysed to determine the levels of Forkhead box 3 (Foxp3) T cells, TGF-β1, CD14 (soluble and surface isoforms), IL-17 and bacterial translocation products. These measurements were correlated to the severity of liver fibrosis, measured with the FIB-4 score and transient elastography. Results Foxp3T cell levels were significantly elevated in HIV mono-infected and co-infected groups ( p &lt; 0.0005). FIB-4 and liver stiffness values inversely correlated with TGF-β1 ( p = 0.0155 and p = 0.0498). Bacterial DNA differed significantly in the HIV-positive compared to the other groups: HIV/HCV co-infected subjects had significantly higher serum levels of bacterial translocation products, CD14, and IL-17 levels ( p &lt; 0.001). Conclusions Fibrosis stage in HIV/HCV co-infection may be influenced by immune activation due either by viral infections or to bacterial translocation.</description><subject>Adult</subject><subject>Bacterial Translocation</subject><subject>Biomarkers - blood</subject><subject>Case-Control Studies</subject><subject>CD4-Positive T-Lymphocytes - cytology</subject><subject>Coinfection</subject><subject>Cross-Sectional Studies</subject><subject>DNA, Bacterial - genetics</subject><subject>Elasticity Imaging Techniques</subject><subject>Female</subject><subject>Gastroenterology and Hepatology</subject><subject>Hepacivirus</subject><subject>Hepatitis C - immunology</subject><subject>HIV immunity</subject><subject>HIV Infections - immunology</subject><subject>HIV/HCV co-infection</subject><subject>Humans</subject><subject>Interleukin-17 - blood</subject><subject>Linear Models</subject><subject>Lipopolysaccharide Receptors - blood</subject><subject>Liver Cirrhosis - diagnosis</subject><subject>Liver Cirrhosis - virology</subject><subject>Liver fibrosis</subject><subject>Male</subject><subject>Middle Aged</subject><subject>RNA, Viral - genetics</subject><subject>Transforming Growth Factor beta1 - blood</subject><issn>1590-8658</issn><issn>1878-3562</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp9kU1v1DAQhi1ERUvhB3BBOXIgqccfiVdISGhV2EorcQAqbpbjjCVvk7jYyUpV_zxOU3rg0JM_5nlHmmcIeQe0Agr1xaHq-q5iFEQFUFFgL8gZqEaVXNbsZb7LDS1VLdUpeZ3SgVIGtaSvyCmTUohaNmfkfu-PGAvn2xiSTx-LwdsYWm_6YopmTH2wZvJhLMzYFX4Y5hELYyd_XH8HE28wpsKPxe7q-gHaba_z06FdgLTmHqoXS8WG8qn4hpw40yd8-3iek19fL39ud-X--7er7Zd9aSWDqWxsJyQKCtQ4KfNotWsMp-gUN07ULXfGbRq1QZTOUt4KQ1uZAQbIO84UPycf1r63MfyZMU168Mli35sRw5x0lqIESK42GYUVzRJSiuj0bfR5yDsNVC_O9UFn53pxrgF0dp4z7x_bz-2A3VPin-QMfFoBzEMePUadrMfRYudjNqG74J9t__m_tO396K3pb_AO0yHMccz2NOjENNU_lqUvOwdBqaLNb_4XQ8-m5g</recordid><startdate>20150301</startdate><enddate>20150301</enddate><creator>Sacchi, Paolo</creator><creator>Cima, Serena</creator><creator>Corbella, Marta</creator><creator>Comolli, Giuditta</creator><creator>Chiesa, Antonella</creator><creator>Baldanti, Fausto</creator><creator>Klersy, Catherine</creator><creator>Novati, Stefano</creator><creator>Mulatto, Patrizia</creator><creator>Mariconti, Mara</creator><creator>Bazzocchi, Chiara</creator><creator>Puoti, Massimo</creator><creator>Pagani, Laura</creator><creator>Filice, Gaetano</creator><creator>Bruno, Raffaele</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150301</creationdate><title>Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection</title><author>Sacchi, Paolo ; Cima, Serena ; Corbella, Marta ; Comolli, Giuditta ; Chiesa, Antonella ; Baldanti, Fausto ; Klersy, Catherine ; Novati, Stefano ; Mulatto, Patrizia ; Mariconti, Mara ; Bazzocchi, Chiara ; Puoti, Massimo ; Pagani, Laura ; Filice, Gaetano ; Bruno, Raffaele</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c521t-7cd45e4010af553566f7a30ef83af46b3faf9789ee5fc03b4a0b5a3021e3d3283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Bacterial Translocation</topic><topic>Biomarkers - blood</topic><topic>Case-Control Studies</topic><topic>CD4-Positive T-Lymphocytes - cytology</topic><topic>Coinfection</topic><topic>Cross-Sectional Studies</topic><topic>DNA, Bacterial - genetics</topic><topic>Elasticity Imaging Techniques</topic><topic>Female</topic><topic>Gastroenterology and Hepatology</topic><topic>Hepacivirus</topic><topic>Hepatitis C - immunology</topic><topic>HIV immunity</topic><topic>HIV Infections - immunology</topic><topic>HIV/HCV co-infection</topic><topic>Humans</topic><topic>Interleukin-17 - blood</topic><topic>Linear Models</topic><topic>Lipopolysaccharide Receptors - blood</topic><topic>Liver Cirrhosis - diagnosis</topic><topic>Liver Cirrhosis - virology</topic><topic>Liver fibrosis</topic><topic>Male</topic><topic>Middle Aged</topic><topic>RNA, Viral - genetics</topic><topic>Transforming Growth Factor beta1 - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sacchi, Paolo</creatorcontrib><creatorcontrib>Cima, Serena</creatorcontrib><creatorcontrib>Corbella, Marta</creatorcontrib><creatorcontrib>Comolli, Giuditta</creatorcontrib><creatorcontrib>Chiesa, Antonella</creatorcontrib><creatorcontrib>Baldanti, Fausto</creatorcontrib><creatorcontrib>Klersy, Catherine</creatorcontrib><creatorcontrib>Novati, Stefano</creatorcontrib><creatorcontrib>Mulatto, Patrizia</creatorcontrib><creatorcontrib>Mariconti, Mara</creatorcontrib><creatorcontrib>Bazzocchi, Chiara</creatorcontrib><creatorcontrib>Puoti, Massimo</creatorcontrib><creatorcontrib>Pagani, Laura</creatorcontrib><creatorcontrib>Filice, Gaetano</creatorcontrib><creatorcontrib>Bruno, Raffaele</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Digestive and liver disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sacchi, Paolo</au><au>Cima, Serena</au><au>Corbella, Marta</au><au>Comolli, Giuditta</au><au>Chiesa, Antonella</au><au>Baldanti, Fausto</au><au>Klersy, Catherine</au><au>Novati, Stefano</au><au>Mulatto, Patrizia</au><au>Mariconti, Mara</au><au>Bazzocchi, Chiara</au><au>Puoti, Massimo</au><au>Pagani, Laura</au><au>Filice, Gaetano</au><au>Bruno, Raffaele</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection</atitle><jtitle>Digestive and liver disease</jtitle><addtitle>Dig Liver Dis</addtitle><date>2015-03-01</date><risdate>2015</risdate><volume>47</volume><issue>3</issue><spage>218</spage><epage>225</epage><pages>218-225</pages><issn>1590-8658</issn><eissn>1878-3562</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>Abstract Background Liver fibrosis is accelerated in patients co-infected with human immunodeficiency virus and hepatitis C viruses. Aims We investigated the correlation between liver fibrosis, immune activation and microbial translocation. Methods This cross-sectional study included patients with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) mono-infections, HIV/HCV co-infection, and healthy controls (20 subjects/group). Peripheral blood was analysed to determine the levels of Forkhead box 3 (Foxp3) T cells, TGF-β1, CD14 (soluble and surface isoforms), IL-17 and bacterial translocation products. These measurements were correlated to the severity of liver fibrosis, measured with the FIB-4 score and transient elastography. Results Foxp3T cell levels were significantly elevated in HIV mono-infected and co-infected groups ( p &lt; 0.0005). FIB-4 and liver stiffness values inversely correlated with TGF-β1 ( p = 0.0155 and p = 0.0498). Bacterial DNA differed significantly in the HIV-positive compared to the other groups: HIV/HCV co-infected subjects had significantly higher serum levels of bacterial translocation products, CD14, and IL-17 levels ( p &lt; 0.001). Conclusions Fibrosis stage in HIV/HCV co-infection may be influenced by immune activation due either by viral infections or to bacterial translocation.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>25544657</pmid><doi>10.1016/j.dld.2014.11.012</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1590-8658
ispartof Digestive and liver disease, 2015-03, Vol.47 (3), p.218-225
issn 1590-8658
1878-3562
language eng
recordid cdi_proquest_miscellaneous_1658415389
source ScienceDirect Journals
subjects Adult
Bacterial Translocation
Biomarkers - blood
Case-Control Studies
CD4-Positive T-Lymphocytes - cytology
Coinfection
Cross-Sectional Studies
DNA, Bacterial - genetics
Elasticity Imaging Techniques
Female
Gastroenterology and Hepatology
Hepacivirus
Hepatitis C - immunology
HIV immunity
HIV Infections - immunology
HIV/HCV co-infection
Humans
Interleukin-17 - blood
Linear Models
Lipopolysaccharide Receptors - blood
Liver Cirrhosis - diagnosis
Liver Cirrhosis - virology
Liver fibrosis
Male
Middle Aged
RNA, Viral - genetics
Transforming Growth Factor beta1 - blood
title Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T20%3A31%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Liver%20fibrosis,%20microbial%20translocation%20and%20immune%20activation%20markers%20in%20HIV%20and%20HCV%20infections%20and%20in%20HIV/HCV%20co-infection&rft.jtitle=Digestive%20and%20liver%20disease&rft.au=Sacchi,%20Paolo&rft.date=2015-03-01&rft.volume=47&rft.issue=3&rft.spage=218&rft.epage=225&rft.pages=218-225&rft.issn=1590-8658&rft.eissn=1878-3562&rft_id=info:doi/10.1016/j.dld.2014.11.012&rft_dat=%3Cproquest_cross%3E1658415389%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c521t-7cd45e4010af553566f7a30ef83af46b3faf9789ee5fc03b4a0b5a3021e3d3283%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1658415389&rft_id=info:pmid/25544657&rfr_iscdi=true